MedTrace Logo

Data Bank for Eosinophilic Disorders

NCT00267475 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2013-09-19

No results posted yet for this study

Summary

The purpose of this study is to conduct a translational study in patients with primary eosinophil associated gastrointestinal disorders \[EGID\] (e.g. eosinophilic esophagitis eosinophilic gastritis, eosinophilic enteritis \[EE\], eosinophilic colitis, and eosinophilic gastroenteritis \[EGE\]) with the aim of developing a data bank containing pertinent patient demographic information, tissue samples, and DNA, which will facilitate research on the pathophysiology of inflammatory disorders and the development of a verified successful clinical treatment program.

Conditions

  • Eosinophilic Esophagitis
  • Gastritis
  • Enteritis
  • Eosinophilic Colitis
  • Eosinophilic Gastroenteritis

Sponsors & Collaborators

  • Marc Rothenberg

    lead OTHER

Principal Investigators

  • Marc E. Rothenberg, M.D., Ph.D. · Children's Hospital Medical Center, Cincinnati

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2001-05-31
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00267475 on ClinicalTrials.gov